Skip to main content
Signal8

Saadi Ryan H.

SEC insider (Form 3/4/5 filer). CIK 0002011728. Chief Executive Officer at Tevogen Inc. (TVGN). 7 reported Form 4/5 transactions since Sep 2024; latest on Sep 14, 2026. Located in WARREN, NJ.

Companies Saadi Ryan H. has filed insider reports for

  • Tevogen Inc. (TVGN): Director, Officer, 10% Owner, Chief Executive Officer
Saadi Ryan H. profile photo

Saadi Ryan H.

CIK: 0002011728

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (14.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (42.9%)

Compensation grants

Other (G, F, J, C, D, …)3 (42.9%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Tevogen Inc. logo
TVGN

Tevogen Inc.

DirectorOfficer10% Owner

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • Tevogen Inc. logo
    TVGN

    Tevogen Inc.

    Sep 14, 2026
    Award
    Direct
    8M shares-
  • Tevogen Bio Holdings Inc. logo
    TVGN

    Tevogen Bio Holdings Inc.

    Jul 10, 2026
    Award
    Direct
    1.2M shares-
  • Tevogen Bio Holdings Inc. logo
    TVGN

    Tevogen Bio Holdings Inc.

    Dec 18, 2025
    Gift
    Direct
    50K shares-
  • Tevogen Bio Holdings Inc. logo
    TVGN

    Tevogen Bio Holdings Inc.

    Dec 11, 2025
    Gift
    Direct
    460K shares-
  • Tevogen Bio Holdings Inc. logo
    TVGN

    Tevogen Bio Holdings Inc.

    Aug 15, 2025
    Gift
    Direct
    20K shares-
  • Tevogen Bio Holdings Inc. logo
    TVGN

    Tevogen Bio Holdings Inc.

    Jun 27, 2025
    Award
    Direct
    8M shares-
  • Tevogen Bio Holdings Inc. logo
    TVGN

    Tevogen Bio Holdings Inc.

    Jun 9, 2025
    Sale
    Direct
    1.4M shares at avg. $1.23$1.8M

1-7 of 7